SDEV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NovaBay Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.93 USD -4.99% Market Closed

Market Cap: $46.9m

N	NovaBay Pharmaceuticals Inc AMEX:SDEV	US
	Phi Group Inc OTC:PHIG	US
B	Baker Hughes Co NASDAQ:BKR	US
	BJ's Restaurants Inc NASDAQ:BJRI	US
P	Primo Service Solutions PCL SET:PRI	TH
I	I2 Enterprise PCL SET:I2	TH
T	Thanachart Capital PCL SET:TCAP	TH
K	Kiang Huat Sea Gull Trading Frozen Food PCL SET:CHOTI	TH
S	Sportech PLC F:ROEA	UK

Profitability Summary

NovaBay Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

37%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-122%

Operating Margin is Increasing

-85% > 58%

Exceptional Net Margin

1 735%

Negative 3Y Average Net Margin

-267%

Net Margin is Increasing

-130% > 1 735%

Negative Free Cash Flow Margin

-3%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-42% > -3%

Exceptional ROE

735%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-121%

ROIC is Increasing

-97% > 26%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.